Pulmonology Devices Market Report 2025

This Pulmonology Devices market report provides a comprehensive analysis of the market’s characteristics, size, and growth, including segmentation, regional and country-level breakdowns, competitive landscape, market shares, trends, and strategies. It also tracks historical and forecasted market growth across various geographies.

The pulmonology devices market size has grown rapidly in recent years. It will grow from $1.36 billion in 2024 to $1.51 billion in 2025 at a compound annual growth rate (CAGR) of 11%. The growth in the historic period can be attributed to rising incidence of chronic respiratory diseases, growing shift towards preventive healthcare, increase in adoption of pulmonology devices, surge in incidence of diseases requiring endoscopic ultrasound procedures, increase in geriatric population.

The pulmonology devices market size is expected to see rapid growth in the next few years. It will grow to $2.26 billion in 2029 at a compound annual growth rate (CAGR) of 10.7%. The growth in the forecast period can be attributed to rise in prevalence of respiratory diseases, rising air pollution levels, growth in home healthcare, growing awareness and early diagnosis, expansion of healthcare infrastructure. Major trends in the forecast period include integration of artificial intelligence, growth of telemedicine and remote monitoring, advancements in portable and wearable devices, use of robotic technology in less-invasive diagnostic procedures, increase in home care services.

The increasing prevalence of respiratory diseases is anticipated to drive the growth of the pulmonology devices market in the future. Respiratory diseases encompass a range of medical conditions affecting organs and tissues involved in breathing, including the airways, lungs, and respiratory muscles. The rise in cases of respiratory diseases is due to factors such as increasing air pollution, smoking, and occupational hazards. Pulmonology devices support respiratory disease management by enabling precise diagnosis, continuous monitoring, and effective treatment through tools such as spirometers, inhalers, pulse oximeters, and ventilators, thereby enhancing patient outcomes and quality of life. For example, in June 2024, the Australian Institute of Health and Welfare, an Australian health and welfare agency, reported that approximately 8.5 million people in Australia, or 34% of the population, were estimated to have chronic respiratory conditions. This includes an estimated 2.8 million people, or 11% of the population, with asthma and 638,000 people, or 2.5% of the population, with chronic obstructive pulmonary disease (COPD). Therefore, the rise in respiratory disease prevalence is fueling growth in the pulmonology devices market.

Leading companies in the pulmonology devices market are focusing on developing innovative products incorporating advanced technologies to enhance patient comfort, treatment efficacy, and the management of various respiratory conditions. One such technology is bilevel positive airway pressure (BiPAP), which provides two pressure settings - one for inhalation (IPAP) and one for exhalation (EPAP) - offering more comfortable continuous pressure for users. For instance, in February 2024, ResMed, a US-based company specializing in cloud-connected medical devices, launched the AirCurve 11 series of advanced BiPAP machines. The AirCurve 11 VAuto model adjusts pressure during exhalation to align more closely with the patient's natural breathing pattern, enhancing comfort and compliance for conditions such as sleep apnea. Additionally, the AirCurve 11 ASV model utilizes adaptive servo-ventilation (ASV) technology, which monitors and adjusts ventilation 50 times per second to stabilize the patient's breathing patterns. These innovations demonstrate a commitment to improving respiratory care through cutting-edge technologies in pulmonology devices.

In March 2022, Sandoz, a subsidiary of Novartis, a Switzerland-based pharmaceutical company, completed the acquisition of Coalesce Product Development Limited for an undisclosed sum. This acquisition is expected to strengthen Sandoz's portfolio in respiratory medicines and enhance patient access to advanced, high-quality therapies. Coalesce Product Development Limited, based in the UK, specializes in medical and drug delivery devices within the respiratory markets, leveraging expertise in mechanical engineering, electronics, and industrial design.

Major companies operating in the pulmonology devices market are Medtronic, Koninklijke Philips N.V., GE Healthcare, Baxter, Boston Scientific Corporation, Medline Industries LP., Olympus Corporation, Omron Healthcare, ResMed, Getinge, ICU Medical Inc., Fisher & Paykel Healthcare Limited, Ambu A/S, Vyaire Medical Inc., Drive DeVilbiss Healthcare, PENTAX Medical, Hamilton Medical, Nonin Medical, CAIRE Inc., Pulmonx Corporation, Verathon Inc., Draegerwerk AG & Co. KGaA, NIOX.

North America was the largest region in the pulmonology devices market in 2024. The regions covered in the pulmonology devices market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the pulmonology devices market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

Pulmonology devices encompass medical instruments and equipment employed for diagnosing, treating, and managing respiratory system conditions and diseases. These devices are essential for evaluating lung function, monitoring respiratory health, administering therapeutic interventions, and supporting patients with respiratory disorders.

Key products within the pulmonology devices market include endobronchial ultrasound (EBUS) needles, pulmonary biopsy devices, airway stents, single-use bronchoscopes, and other specialized tools. EBUS needles, utilized during bronchoscopy, are designed for collecting tissue samples from the lungs and nearby lymph nodes. They are used in various conditions such as chronic obstructive pulmonary disease (COPD), lung cancer, tracheal and bronchial stenosis, foreign body extraction, among others. These devices find application in pulmonology clinics, hospitals, and ambulatory surgical centers.

The pulmonology devices market research report is one of a series of new reports that provides pulmonology devices market statistics, including the pulmonology devices industry global market size, regional shares, competitors with pulmonology devices market share, detailed pulmonology devices market segments, market trends, and opportunities, and any further data you may need to thrive in the pulmonology devices industry. These pulmonology devices market research reports deliver a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

The pulmonary devices market consists of sales of spirometers, peak flow meters, nebulizers, and pulse oximeters. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

This product will be delivered within 3-5 business days.